- Home
- VIGL
as 04-22-2025 4:00pm EST
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | WATERTOWN |
| Market Cap: | 74.7M | IPO Year: | 2022 |
| Target Price: | $16.33 | AVG Volume (30 days): | 141.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.07 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.31 - $6.06 | Next Earning Date: | 05-06-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Vigil Neuroscience Inc. News
VIGL Breaking Stock News: Dive into VIGL Ticker-Specific Updates for Smart Investing
GlobeNewswire
21 days ago
Vigil Neuroscience Presents Data on its Small Molecule TREM2 Agonist VG-3927 in Two Oral Presentations at AD/PD™ 2025 International Conference
MT Newswires
23 days ago
Vigil Neuroscience Files Secondary Stock Shelf
Zacks
a month ago
Vigil Neuroscience (VIGL) Upgraded to Buy: Here's What You Should Know
MT Newswires
a month ago
Wedbush Cuts Price Target on Vigil Neuroscience to $13 From $24, Keeps Outperform Rating
GlobeNewswire
a month ago
Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates
GlobeNewswire
a month ago
Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum
Simply Wall St.
2 months ago
Will Vigil Neuroscience (NASDAQ:VIGL) Spend Its Cash Wisely?
Insider Monkey
2 months ago
Why Vigil Neuroscience, Inc. (VIGL) is Skyrocketing So Far in 2025
Compare VIGL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VIGL Vigil Neuroscience Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.